NO20035637L - Karbonmonoksyd forbedrer resultatene av vev og organ transplantater og undertrykker apoptose - Google Patents

Karbonmonoksyd forbedrer resultatene av vev og organ transplantater og undertrykker apoptose

Info

Publication number
NO20035637L
NO20035637L NO20035637A NO20035637A NO20035637L NO 20035637 L NO20035637 L NO 20035637L NO 20035637 A NO20035637 A NO 20035637A NO 20035637 A NO20035637 A NO 20035637A NO 20035637 L NO20035637 L NO 20035637L
Authority
NO
Norway
Prior art keywords
carbon monoxide
tissue
results
organ transplants
suppresses apoptosis
Prior art date
Application number
NO20035637A
Other languages
English (en)
Norwegian (no)
Other versions
NO20035637D0 (no
Inventor
Fritz H Bach
Leo E Otterbein
Edda M Tobiasch
Jeanne GOSE
Miguel P Soares
Original Assignee
Jeanne GOSE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27404726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20035637(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jeanne GOSE filed Critical Jeanne GOSE
Publication of NO20035637D0 publication Critical patent/NO20035637D0/no
Publication of NO20035637L publication Critical patent/NO20035637L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20035637A 2001-06-21 2003-12-17 Karbonmonoksyd forbedrer resultatene av vev og organ transplantater og undertrykker apoptose NO20035637L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30028901P 2001-06-21 2001-06-21
US33434001P 2001-11-29 2001-11-29
US33797401P 2001-12-07 2001-12-07
PCT/US2002/019687 WO2003000114A2 (en) 2001-06-21 2002-06-21 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis

Publications (2)

Publication Number Publication Date
NO20035637D0 NO20035637D0 (no) 2003-12-17
NO20035637L true NO20035637L (no) 2004-02-17

Family

ID=27404726

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035637A NO20035637L (no) 2001-06-21 2003-12-17 Karbonmonoksyd forbedrer resultatene av vev og organ transplantater og undertrykker apoptose

Country Status (25)

Country Link
US (2) US7238469B2 (de)
EP (2) EP1404811B1 (de)
JP (1) JP4521183B2 (de)
KR (1) KR20040032115A (de)
CN (1) CN100502650C (de)
AT (1) ATE413883T1 (de)
AU (2) AU2002318377B2 (de)
BG (1) BG108492A (de)
BR (1) BR0210599A (de)
CA (1) CA2451266A1 (de)
CY (1) CY1108798T1 (de)
CZ (1) CZ20033448A3 (de)
DE (1) DE60229848D1 (de)
DK (1) DK1404811T3 (de)
ES (1) ES2316583T3 (de)
HU (1) HUP0400371A3 (de)
MX (1) MXPA03012031A (de)
NO (1) NO20035637L (de)
NZ (1) NZ562962A (de)
PL (1) PL367544A1 (de)
PT (1) PT1404811E (de)
SG (1) SG147305A1 (de)
SI (1) SI1404811T1 (de)
SK (1) SK15942003A3 (de)
WO (1) WO2003000114A2 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128963B2 (en) * 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
US7678390B2 (en) 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
EP1404811B1 (de) 2001-06-21 2008-11-12 Beth Israel Deaconess Medical Center, Inc. Kohlenmonoxid verbessert die ergebnisse bei gewebe- und organtransplantationen und unterdrückt apoptose
EP2042181A1 (de) * 2002-02-04 2009-04-01 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Verwendung CO- freisetzender Substanzen zur Herstellung eines Medikaments für die Behandlung entzündlicher Erkrankungen
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
CA2475963A1 (en) 2002-02-13 2003-09-04 Beth Israel Deaconess Medical Center, Inc. Methods of treating vascular disease
EP1499328B1 (de) 2002-04-15 2015-09-16 University of Pittsburgh - Of the Commonwealth System of Higher Education Verfahren zur behandlung von nekrotisierender enterocolitis
JP2005522521A (ja) * 2002-04-15 2005-07-28 ベス イスラエル デアコネス メディカル センター ヘムオキシゲナーゼ−１およびヘム分解産物の使用法
ES2546280T3 (es) 2002-04-15 2015-09-22 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Monóxido de carbono para su uso en un método para tratar íleo
EP1505990B1 (de) * 2002-05-17 2011-08-24 Yale University Verfahren zur behandlung von hepatitis
JP2005532351A (ja) * 2002-06-05 2005-10-27 イエール ユニバーシティ 血管形成、腫瘍増殖、および転移を治療する方法
CA2490392A1 (en) * 2002-06-21 2003-12-31 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
AU2003283982A1 (en) * 2002-11-07 2004-06-03 University Of Pittsburgh Of The Commonwealth System Of High Education Treatment for hemorrhagic shock
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
EP1684580A2 (de) * 2003-10-22 2006-08-02 Fred Hutchinson Cancer Research Center Verfahren, zusammensetzungen und vorrichtungen zur induktion von stasen geweben und organen
EP1552840A1 (de) * 2004-01-07 2005-07-13 Aga Ab Mischung aus Xenon und Kohlenmonoxyd zum Schutz von Zellen
WO2006096774A2 (en) 2005-03-07 2006-09-14 Sangart, Inc. Composition and methods for delivering carbon monoxide (co) and nitric ozide (no) co to tissue using heme proteins as carriers
WO2007014380A2 (en) 2005-07-27 2007-02-01 University Of North Carolina At Charlotte Composition and method for the restoration and preservation of transplant organs procured from dcd donors
US20070207993A1 (en) * 2005-12-20 2007-09-06 Alfama - Investigacao E Desenvolvimetno De Productos Farmaceuticos Lda Molybdenum carbonyl complexes for treating rheumatoid arthritis and other inflammatory diseases
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
CL2007003193A1 (es) 2006-11-07 2008-07-04 Gen Hospital Corp Metodo para evitar o reducir la vasoconstriccion a continuacion de la administracion de un portador de oxigeno vasoactivo, que comprende oxido nitrico gaseoso y otro agente activo; composicion farmaceutica que comprende un inhibidor de fosfodiesteras
LT3210644T (lt) 2009-05-27 2019-02-11 Ino Therapeutics Llc Įrenginiai, skirti sugraduoto vožtuvo ir hermetiško kanistro įrenginio sukabinimui be sandariklio
CA2671029A1 (en) 2009-06-30 2010-12-30 James S. Baldassarre Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
WO2012096912A1 (en) * 2011-01-14 2012-07-19 Children's Hospital Los Angeles Solution of carbon monoxide for treatment of disease, including sickle cell disease
US8927750B2 (en) 2011-02-04 2015-01-06 Universitaet Zu Koeln Acyloxy- and phosphoryloxy-butadiene-Fe(CO)3 complexes as enzyme-triggered co-releasing molecules
KR20140033015A (ko) 2011-03-16 2014-03-17 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 적혈구 조제물 및 혈소판 조제물의 유효 저장성을 연장하는 방법 및 물질
US9163044B2 (en) 2011-04-19 2015-10-20 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
EP3391891A3 (de) * 2011-06-10 2019-01-02 VERO Biotech LLC Stickoxiddruckbehälter
EP2734235B1 (de) 2011-07-21 2017-03-22 Alfama, Inc. Kohlenmonoxidfreisetzende rutheniummoleküle und ihre verwendungen
WO2013022946A1 (en) 2011-08-09 2013-02-14 Beth Israel Deaconess Medical Center, Inc. Methods of treating dna damage
US9629358B2 (en) 2013-03-15 2017-04-25 Mallinckrodt Hospital Products IP Limited Administration and monitoring of nitric oxide in ex vivo fluids
ES2981406T3 (es) 2013-03-15 2024-10-08 Mallinckrodt Pharmaceuticals Ireland Ltd Administración y monitorización de óxido nítrico en fluidos ex vivo
TW201618795A (zh) 2014-04-15 2016-06-01 波泰里斯股份有限公司 用以改良器官功能及延長器官移植物壽命之系統及方法
WO2017027810A2 (en) 2015-08-12 2017-02-16 The General Hospital Corporation Compositions and methods that promote hypoxia or the hypoxia response for treatment and prevention of mitochondrial dysfunction and oxidative stress disorders
CN105288599A (zh) * 2015-10-22 2016-02-03 徐州医学院 血红素氧化酶-2在制备抑制器官移植免疫排斥制剂中的应用
KR20240142604A (ko) 2017-08-25 2024-09-30 말린크로트 파마슈티칼스 아일랜드 리미티드 기관 생존력을 개선시키는 방법
EP3524290A1 (de) 2018-02-09 2019-08-14 Julius-Maximilians-Universitaet Wuerzburg Verfahren und system zur überwachung der kohlenmonoxid(co)-verabreichung an ex-vivo-flüssigkeiten
CN116076484A (zh) * 2022-11-30 2023-05-09 武汉大学 一种修复肾脏损伤的低温携氧机械灌注液及其应用

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053590A (en) 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4264739A (en) * 1979-01-05 1981-04-28 Merck & Co., Inc. Sparger for cell culture system
JPS5679957A (en) 1979-12-05 1981-06-30 Sogo Seibutsu Igaku Kenkyusho:Kk Erucinia enterocolitica polysaccharide sensitizing blood cell and method of detecting erucinia enterocolitica polysaccharide antibody using this
US5240912A (en) 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
US5084380A (en) 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
CN85202057U (zh) * 1985-05-31 1986-09-10 南京低压阀门厂 电热丝预热凹槽式燃油系统
US5449665A (en) 1985-09-24 1995-09-12 Item Development Aktiebolag Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty
DE3739650C1 (de) * 1987-11-23 1989-05-24 Immuno Ag Fermenter zum Zuechten von Zellkulturen
DE3928144A1 (de) * 1989-08-25 1991-02-28 Hoechst Ag Zyklische pyridin-2,4- und -2,5-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
US5180366A (en) 1990-10-10 1993-01-19 Woods W T Apparatus and method for angioplasty and for preventing re-stenosis
US5792325A (en) 1990-11-15 1998-08-11 Richardson, Jr.; William H. Electric arc material processing system
US5570683A (en) 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
US5293875A (en) 1992-06-16 1994-03-15 Natus Medical Incorporated In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods
PT693924E (pt) * 1993-02-22 2004-09-30 American Biosciences Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
AU6523194A (en) * 1993-03-26 1994-10-24 Biorelease Technologies, Inc. Compositions including heme-containing proteins and methods relating thereto
US5763431A (en) 1993-08-20 1998-06-09 Jackson; Meyer B. Method for regulating neuropeptide hormone secretion
DE4421433C1 (de) 1994-06-18 1995-06-08 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung
US5476764A (en) * 1994-09-16 1995-12-19 The Regents Of The University Of California Method using CO for extending the useful shelf-life of refrigerated red blood cells
US6066333A (en) 1994-09-22 2000-05-23 William Harvey Research Limited Pharmaceutical control of inflammation
US5664563A (en) 1994-12-09 1997-09-09 Cardiopulmonary Corporation Pneumatic system
US5914316A (en) 1994-12-16 1999-06-22 Washington University Method of inhibiting intimal hyperplasia
US6063407A (en) 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5712293A (en) 1995-06-07 1998-01-27 Sepracor, Inc. Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride
FR2735382B1 (fr) * 1995-06-15 1997-07-25 Air Liquide Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique
AU5938696A (en) 1995-06-30 1997-02-05 Zymogenetics Inc. 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists
ATE331505T1 (de) 1996-04-05 2006-07-15 Gen Hospital Corp Behandlung einer hämoglobinstörung
US6069132A (en) 1996-08-14 2000-05-30 Revanker; Ganapathi R. Phosphazole compounds
DK0921807T3 (da) 1996-08-27 2004-03-15 Messer Griesheim Gmbh Hydrogenholdigt lægemiddel
US6315995B1 (en) 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US6316403B1 (en) 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
ATE358492T1 (de) * 1996-09-27 2007-04-15 Univ Columbia Behandlung einer ischämischen störung und zur verbesserung des infarktergebnis
US8128963B2 (en) * 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
US5869538A (en) * 1996-11-26 1999-02-09 Research Foundation Of State University Of New York Method for enhancing transport of gases to tissues
FR2757259B1 (fr) * 1996-12-18 1999-03-05 Valeo Thermique Moteur Sa Ailette metallique perfectionnee pour echangeur de chaleur, notamment pour vehicule automobile
US5912019A (en) * 1997-02-07 1999-06-15 Musc Foundation For Research Development Compounds for reducing ischemia/reperfusion injury
CZ299253B6 (cs) 1998-03-16 2008-05-28 Celgene Corporation Isoindolinový derivát, jeho použití pro výrobu léciva a farmaceutická kompozice tento derivát obsahující
US6203991B1 (en) 1998-08-21 2001-03-20 The Regents Of The University Of Michigan Inhibition of smooth muscle cell migration by heme oxygenase I
US20050250688A1 (en) 1999-04-01 2005-11-10 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US7678390B2 (en) * 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US6558825B1 (en) * 2000-05-12 2003-05-06 Reveo, Inc. Fuel containment and recycling system
FR2812197B1 (fr) 2000-07-27 2003-01-03 Air Liquide Sante Int Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
FR2816212A1 (fr) 2000-11-03 2002-05-10 Air Liquide Sante Int Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire
BR0208012A (pt) 2001-03-20 2004-03-02 Glaxo Group Ltd Usos de pelo menos duas drogas e um propelente hfa e de pelo menos uma composição farmaceêutica, e, inalador acondicionado para tratar asma
EP1381354A2 (de) * 2001-03-30 2004-01-21 Sangstat Medical Corporation Kohlenmonoxid erzeugende verbindungen zur behandlung von gefäss-, entzündlichen und immunerkrankungen
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
WO2002096387A1 (en) 2001-05-25 2002-12-05 Medtronic, Inc. Implantable medical device with controllable gaseous agent release system
EP1404811B1 (de) * 2001-06-21 2008-11-12 Beth Israel Deaconess Medical Center, Inc. Kohlenmonoxid verbessert die ergebnisse bei gewebe- und organtransplantationen und unterdrückt apoptose
EP2042181A1 (de) 2002-02-04 2009-04-01 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Verwendung CO- freisetzender Substanzen zur Herstellung eines Medikaments für die Behandlung entzündlicher Erkrankungen
CA2475963A1 (en) * 2002-02-13 2003-09-04 Beth Israel Deaconess Medical Center, Inc. Methods of treating vascular disease
EP1499328B1 (de) * 2002-04-15 2015-09-16 University of Pittsburgh - Of the Commonwealth System of Higher Education Verfahren zur behandlung von nekrotisierender enterocolitis
JP2005522521A (ja) * 2002-04-15 2005-07-28 ベス イスラエル デアコネス メディカル センター ヘムオキシゲナーゼ−１およびヘム分解産物の使用法
ES2546280T3 (es) * 2002-04-15 2015-09-22 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Monóxido de carbono para su uso en un método para tratar íleo
EP1505990B1 (de) * 2002-05-17 2011-08-24 Yale University Verfahren zur behandlung von hepatitis
JP2005532351A (ja) * 2002-06-05 2005-10-27 イエール ユニバーシティ 血管形成、腫瘍増殖、および転移を治療する方法
CA2490392A1 (en) * 2002-06-21 2003-12-31 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
AU2003283982A1 (en) * 2002-11-07 2004-06-03 University Of Pittsburgh Of The Commonwealth System Of High Education Treatment for hemorrhagic shock
WO2005077005A2 (en) * 2004-02-04 2005-08-25 The General Hospital Corporation Enhancing the effectiveness of an inhaled therapeutic gas

Also Published As

Publication number Publication date
EP1404811A2 (de) 2004-04-07
DK1404811T3 (da) 2009-03-02
PL367544A1 (en) 2005-02-21
ES2316583T3 (es) 2009-04-16
WO2003000114A3 (en) 2003-04-10
CY1108798T1 (el) 2014-04-09
CN1545548A (zh) 2004-11-10
HUP0400371A3 (en) 2010-06-28
EP1404811B1 (de) 2008-11-12
CN100502650C (zh) 2009-06-24
WO2003000114A9 (en) 2004-05-21
SG147305A1 (en) 2008-11-28
EP2033514A3 (de) 2009-04-29
KR20040032115A (ko) 2004-04-14
MXPA03012031A (es) 2005-07-01
US20070202083A1 (en) 2007-08-30
PT1404811E (pt) 2009-01-22
WO2003000114A2 (en) 2003-01-03
US7238469B2 (en) 2007-07-03
HK1067380A1 (en) 2005-04-08
EP2033514A2 (de) 2009-03-11
BR0210599A (pt) 2004-07-20
NZ562962A (en) 2009-08-28
AU2002318377B2 (en) 2008-06-19
BG108492A (bg) 2005-02-28
JP4521183B2 (ja) 2010-08-11
DE60229848D1 (de) 2008-12-24
AU2008221551A1 (en) 2008-10-09
ATE413883T1 (de) 2008-11-15
CA2451266A1 (en) 2003-01-03
SK15942003A3 (sk) 2004-08-03
HUP0400371A2 (hu) 2004-08-30
SI1404811T1 (sl) 2009-04-30
EP1404811A4 (de) 2006-08-09
US20030039638A1 (en) 2003-02-27
CZ20033448A3 (cs) 2004-05-12
NO20035637D0 (no) 2003-12-17
JP2005500875A (ja) 2005-01-13

Similar Documents

Publication Publication Date Title
NO20035637D0 (no) Karbonmonoksyd forbedrer resultatene av vev og organ transplantater og undertrykker apoptose
EP1624750A4 (de) Zusammensetzung zur aufrechterhaltung der lebensfähigkeit von organen und zellen
WO2004009767A3 (en) Cell therapy for regeneration
MXPA02007137A (es) Fuente de tejido hepatico.
WO2003077865A3 (en) Methods and compositions for directing cells to target organs
EP2465921A3 (de) Herzstammzellen aus der Biopsie
DK1028737T3 (da) Humane mesenchymale stamceller fra perifert blod
NO20033351L (no) Fremgangsmater for a indusere organtransplantasjontoleranse og korrigering av hemoglobinopatier
DE69937888D1 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
WO2007035843A3 (en) Methods and compositions for organ and tissue functionality
ATE550423T1 (de) Dreidimensionale kultivierte gewebe und deren verwendung
WO2004039248A3 (en) Repairing or replacing tissues or organs
WO2003012060A3 (en) Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd
EP1676574A3 (de) Verfahren zur Förderung des Überlebens von Zell- und Gewebe-Transplantaten
WO2007025215A3 (en) Machine perfusion of tissue grafts for transplantation
DK1274464T3 (da) Sammensætninger og fremgangsmåder til regulering af proteinekspression i tarm
DK1178726T3 (da) Vandig opløsning til konservering af væv og organer
EP2216033A3 (de) Behandlungsmethode einer Erkrankung durch Transplantation eines allogenen oder xenogenen Organs oder Gewebe
WO2002098361A3 (en) T cell induced tissue repair and regeneration
WO2003102162A3 (en) Novel tolerogenic dendritic cells and therapeutic uses therefor
MXPA02005069A (es) Agentes de enlace especificos para t3 y metodos para su uso.
WO2005055877A3 (de) Verfahren zur herstellung von bandscheibengewebe aus degeneriertem bandscheibengewebe
EP1728857A3 (de) Bereitstellung von Lebergewebe.
HUP0103107A2 (hu) Allogénikus és xenogénikus T-sejtek ex vivo kezelése gp39 antagonistákkal
WO2024077153A8 (en) Pluripotent stem cell-derived megakaryocytes and platelets

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application